63rd AAN Annual Meeting abstract P05.287 (safinamide) Read more about 63rd AAN Annual Meeting abstract P05.287 (safinamide)
63rd AAN Annual Meeting abstract S33.002 (safinamide) Read more about 63rd AAN Annual Meeting abstract S33.002 (safinamide)
63rd AAN Annual Meeting poster P05.287(safinamide) Read more about 63rd AAN Annual Meeting poster P05.287(safinamide)
Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial Read more about Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial
Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul Read more about Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul
Acquisition of Hunter-Fleming Conference Call Read more about Acquisition of Hunter-Fleming Conference Call
